SCHEMBL6185559

SCHEMBL6185559

CC(C)COC(=O)N1CCC(N(Cc2cccc(Cl)c2Cl)CC2CC2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 9/20 0.49
SLC6A2 P23975 8/20 0.49
SLC6A3 Q01959 6/20 0.49
CYP2D6 P10635 2/20 0.49
CYP3A4 P08684 1/20 0.42
KCNH2 Q12809 1/20 0.42
GPR119 Q8TDV5 1/20 0.40
GHSR Q92847 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
ALDH1A1 P00352 3/20 0.38
USP2 O75604 1/20 0.37
HPGD P15428 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALOX15 P16050 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KIT P10721 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5993906 0.84 SLC6A4 (0.51) SLC6A4SLC6A2SLC6A3CYP2D6GPR119
SCHEMBL3645098 0.74 MEN1 (0.56) SLC6A4SLC6A2GPR119SMN1; SMN2JAK2
SCHEMBL4485498 0.73 SLC6A2 (0.50) SLC6A4SLC6A2SLC6A3CYP2D6CYP3A4
SCHEMBL6183532 0.72 SLC6A2 (0.60) SLC6A4SLC6A2SLC6A3CYP2D6GPR119
Cadaverine Tartrate SCHEMBL5995304 0.72 SLC6A4 (0.70) SLC6A4SLC6A2SLC6A3CYP2D6CYP3A4
SCHEMBL5995080 0.71 SLC6A4 (0.85) SLC6A4SLC6A2SLC6A3CYP2D6CYP3A4
SCHEMBL5997497 0.70 SLC6A2 (0.45) SLC6A4SLC6A2SLC6A3GPR119HTT
Fumaric Acid SCHEMBL5994167 0.69 SLC6A2 (0.70) SLC6A4SLC6A2SLC6A3CYP2D6CYP3A4
Fumaric Acid SCHEMBL5994164 0.69 SLC6A2 (0.70) SLC6A4SLC6A2SLC6A3CYP2D6CYP3A4
SCHEMBL5511565 0.68 SLC6A4 (0.63) SLC6A4SLC6A2SLC6A3CYP2D6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569905-A2 INHIBITORS OF MONOAMINE UPTAKE ELI LILLY AND COMPANY (US) 2005-09-07 EP disclosed
WO-2004052858-A2 INHIBITORS OF MONOAMINE UPTAKE ELI LILLY AND COMPANY (US) 2004-06-24 WO disclosed